BioTech

Spark Therapeutics (ONCE), a commercial gene therapy company, announced Friday that the European Commission has granted marketing authorization for LUXTURNA (voretigene neparvovec).

Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) announced today results from the Ph

TARRYTOWN, N.Y. and PARIS, March 8, 2019 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the U.S. Food an

Source: www.novartis.com The US Food and Drug Administration (FDA) has granted Novartis Breakthrough Therapy designation for its investigational therapy crizanlizumab (SEG101). This revolutionary treatment is...

Inolex has announced it is to develop its US manufacturing facilities, with the new expansion set to replace the company’s current US production and warehouse operations. The expansion is set for completion in the second half of 2019 with a new flagship plant in Charlotte, North Carolina. David Plimpton, Inolex CEO, says, “This is a...

Source: www.marketwatch.com McEwen, a gold and silver producer focused on the Americas, is aiming to quality for inclusion in the S&P 500 index by improving...

Gilead Sciences Inc. (Nasdaq: GILD) and insitro announced today that the companies have entered into a strategic collaboration to discover and develop

Read more about Dr Reddys Laboratories launches Tadalafil Tablets USP in US market on Business Standard. The Cialis brand and generic had U.S. sales of approximately $1.7 billion MAT for the most recent twelve months ending in January 2019 according to IMS Health.

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A...

THOUSAND OAKS, Calif. and BRUSSELS, April 9, 2019 /PRNewswire/ -- Amgen (NASDAQ: AMGN) and UCB (Euronext Brussels: UCB) today announced that the U.S. Foo